Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn Kelly

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|August 1, 2006
Someone to watch over youKath Sharples, Dawn Kelly
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|October 18, 2006
A hard day's nightKath Sharples, Dawn Kelly
Ecology|May 16, 2017
Interspecific combat observed among viperid snakesDavid A Steen, Dawn Kelly
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|December 21, 2006
It will go swimminglyMelanie Gasston-Hales, Dawn Kelly
The Practising Midwife|April 1, 2008
Small world: comparing midwifery practiceCatherine McEvilly, Katie Smith, Dawn Kelly
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|June 16, 2007
Supporting mentors in practiceKathryn Sharples, Dawn Kelly, Karen Elcock
ACS Medicinal Chemistry Letters|June 6, 2014
Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted AgentsRobert L Dow, Philip A Carpino, Denise Gautreau, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2008
Pharmacological characterization of a small molecule inhibitor of c-Jun kinaseHelen Cho, Shawn C Black, David Looper, et al.
Biochemical and Biophysical Research Communications|March 10, 2010
In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesityJohn R Hadcock, David A Griffith, Phillip A Iredale, et al.
BMC Pharmacology|August 18, 2010
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonistJohn R Hadcock, Philip A Carpino, Philip A Iredale, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|August 1, 2006
Someone to watch over youKath Sharples, Dawn Kelly
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|October 18, 2006
A hard day's nightKath Sharples, Dawn Kelly
Ecology|May 16, 2017
Interspecific combat observed among viperid snakesDavid A Steen, Dawn Kelly
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|December 21, 2006
It will go swimminglyMelanie Gasston-Hales, Dawn Kelly
The Practising Midwife|April 1, 2008
Small world: comparing midwifery practiceCatherine McEvilly, Katie Smith, Dawn Kelly
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|June 16, 2007
Supporting mentors in practiceKathryn Sharples, Dawn Kelly, Karen Elcock
ACS Medicinal Chemistry Letters|June 6, 2014
Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted AgentsRobert L Dow, Philip A Carpino, Denise Gautreau, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2008
Pharmacological characterization of a small molecule inhibitor of c-Jun kinaseHelen Cho, Shawn C Black, David Looper, et al.
Biochemical and Biophysical Research Communications|March 10, 2010
In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesityJohn R Hadcock, David A Griffith, Phillip A Iredale, et al.
BMC Pharmacology|August 18, 2010
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonistJohn R Hadcock, Philip A Carpino, Philip A Iredale, et al.
Pageof 2